¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"environmental lung disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • disease registry
    Áúº´µî·Ïü°è
  • disease susceptibility
    Áúº´°¨¼ö¼º
  • disease taxonomy
    Áúº´ºÐ·ùÇÐ
  • extramammary Paget disease
    À¯¹æ¿ÜÆÄÁ¦Æ®º´
  • extrapyramidal disease
    ÇǶó¹Ìµå¹Ù±ù±æº´, Ãßü¿Ü·Îº´
  • endemic disease
    dzÅ亴, Áö¹æÀ¯Çິ
  • enzootic disease
    µ¿¹°Áö¹æº´, µ¿¹°ÅäÂøº´
  • epidemic disease
    À¯Çິ
  • Fabry disease
    ÆÄºê¸®º´
  • fat deficiency disease
    Áö¹æ°áÇ̺´
  • febrile disease
    ¿­º´
  • fibrocystic disease
    ¼¶À¯³¶º´
  • fifth disease
    Á¦5º´, °¨¿°È«¹Ý
  • Fahr disease
    ÆÄ¸£º´
  • fluke disease
    ÈíÃæº´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • endemic disease
    dzÅ亴
  • enzootic disease
    µ¿¹°ÅäÂøº´
  • epidemic disease
    À¯Çິ
  • epidermal-epithelial viral disease
    Ç¥ÇÇ»óÇǹÙÀÌ·¯½ºº´
  • exotic disease
    ¿Ü·¡º´
  • extraarticular rheumatic disease
    °üÀý¿Ü·ù¸¶Æ¼½ºº´
  • extrapyramidal disease
    Ãßü¿Ü·Îº´
  • fat deficiency disease
    Áö¹æ°áÇÌÁõ
  • febrile disease
    ¿­º´
  • fibrocystic disease
    ¼¶À¯³¶º´
  • fibromuscular disease
    ¼¶À¯±ÙÀ°º´
  • fifth disease
    (¢¡erythema infectiosum) °¨¿°È«¹Ý
  • fishskin disease
    (¢¡ichthyosis) ºñ´ÃÁõ
  • fluke disease
    ÈíÃæº´
  • foot process disease
    ¹ßµ¹±âº´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • Hirschsprungs disease
    È÷¸£½¬½ºÇÁ·îº´
  • Hodgkin s disease =malignant lymphoma
    È£ÁîŲº´.
  • Hodgkin s disease =malignant lymphoma
    È£ÁîŲº´.
  • Huntingtons disease
    ÇãÆÃÅæ¹«µµº´
  • Huntingtons disease
    ÇåÆÃÅæ º´
  • Hyaline membrane disease
    À¯¸®Áú¸·º´(ë¤×ãòõدܻ)
  • Internation Classification of Disease(ICD)
    ±¹Á¦Áúº´ºÐ·ù.
  • Jacob-Creutzfeldt disease
    ¾ßÄß-Å©·çÃ÷ÆçÆ®º´
  • Johnes disease
    ÁÔÁúȯ
  • Kahler s disease
    Ä®·¯º´.
  • Kawasaki disease
    °¡¿Í»ç³¢º´, Á¡¸·ÇǺθ²ÇÁÀý ÁõÈıº (±Þ¼º¿­¼º)
  • Kawasaki disease => mucocutaneous lymph node syndrome
    °¡¿Í»çŰ º´
  • Kimura disease
    ±â¹«¶ó º´
  • Krabbe s disease
    Å©¶óº£º´.
  • Krabbes disease
    Å©·¹º£º´
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • middle lung field
    ¹æ»ç Á߯ó¾ß(ñéøËå¯).
  • multilobation of lung
    ¹µ¿±ÇãÆÄ
  • mushroom growers lung
    ¹ö¼¸Àç¹èÀÚÆó
  • mushroom workers lung
    ¹ö¼¸Àç¹è³ëµ¿ÀÚÆó(ËøËÑËÈËÄËö̰).
  • mushroom workers lung ³ª
    ¹ö¼¸Àç¹è³ëµ¿ÀÚÆó(î¨ÛÆÖÌÔÑíºøË).
  • narcotic lung
    ¸¶¾à¼º ÆóÀå(ئå·àõ øËíó)
  • one lung anesthesia
    ÆíÃøÆó¸¶Ãë(ø¸ö°øËØ«ö­).
  • opaque lung
    ¹æ»ç (°áÇÙ)¹«±¸Á¶Æó(ÙíϰðãøË).
  • open lung biopsy
    °³ÈäÆó»ý°Ë(°³ÈäÆó»ý°Ë).
  • open lung biopsy
    °³Èä»ý°Ë(ËÒýØßæËþ).
  • percutaneous lung tap
  • pigeon breeders lung
    ºñµÑ±â»çÀ°»çÆó(¡­ÞøëÀÞÍøË)
  • polycystic lung
    ¹µ¹°È¤ÇãÆÄ
  • pulmo =lung ³ª
    Æó(øË).
  • pulmolith =lung stone
    Æó°á¼®(øËÌ¿à´).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 10
CDILD chronic diffuse interstitial lung disease
CHLD chronic hypoxic lung disease
CNSLD chronic nonspecific lung disease
COLD chronic obstructive lung disease
FLD fibrotic lung disease
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 10
LC Lung Cancer
LCSG Lung Cancer Study Group
LIS Lung Injury Score
LKLF Lung Kruppel Like Factor
LRP Lung Resistance Protein
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • fifth disease
    Á¦ 5º´
  • flat Bowen's disease
    ÆíÆò Bowen Áúȯ
  • focal disease
    ÃÊÁ¡¼º Áúȯ
  • following chronic infectious disease
    ¸¸¼º °¨¿° ÁúȯÀÇ ÃßÀû
  • Fordyce's disease
    Æ÷¿À´ÙÀ̽º º´
  • Hailey-Hailey disease
    ÇìÀϸ® ÇìÀϸ® º´
    °¡Á·¼º ¾ç¼º ¸¸¼º õÆ÷â. °æºÎ, ¾×¿Í, ¼­ÇýºÎ¿¡ ÀÛÀº ¼öÆ÷ ¹× Å« ¼öÆ÷°¡ ¹Ýº¹ÇÏ¿© ¹ß»ýÇÏ´Â Èñ±ÍÇÑ À¯Àü¼º Áúȯ. »ó¿°»öü ¿ì¼º À¯ÀüÀ» ÇÏ¸ç ºÒ¿ÏÀüÇÑ Ç¥ÇöÀ²À» °¡Áø´Ù. ¸ð³¶ °¢È­Áõ°ú À¯»çÇÏ°Ô »ý°¢ÇÏ¸ç ºÎÂø ¹Ý³» ¼¼Æ÷°£ Á¢ÃËÃþÀÇ ¼Ò½Ç ¶Ç´Â ´ç±è¼¼»çÀÇ °áÇÔÀ» µé°í ÀÖ´Ù.
  • hand and foot disease
    ¼Õ¹ß º´, ¼öÁ· º´
  • hand foot and mouth disease
    ¼öÁ·±¸ º´, ¼Õ¹ßÀÔ º´, ¼Õ¹ß ¹× ±¸°­ Áúȯ, ¼Õ-¹ß-±¸°­ Áúȯ
    1. ÄÛ»çŰ ¹ÙÀÌ·¯½º¿¡ ÀÇÇØ »ý±ä µå¹® Àå ¹ÙÀÌ·¯½º¼º °¨¿° Áúȯ. 2. °æÁõÀ̳ª ´ë´ÜÈ÷ °¨¿°·ÂÀÌ ÀÖ´Â ¼Ò¾ÆÀÇ ¹ÙÀÌ·¯½º º´À¸·Î¼­, ÀÔ, ¼öÁ·¿¡ ¼öÆ÷¼º º´º¯À» º¼ ¼ö ÀÖ´Â °ÍÀÌ ±× Ư¡ÀÌ´Ù. 3. ÄÛ»çŰ ¹ÙÀÌ·¯½º A16ÀÇ °¨¿°À¸·Î ¼Õ, ¹ß, ÇÏÁö, ÀÔ¼Ó¿¡ ÀÛÀº ¼öÆ÷°¡ »ý±â´Â Áúº´. ÁÖ·Î Á¥¸ÔÀÌ¿¡°Ô Àß ³ªÅ¸³ª´Â °¨¿°ÁõÀε¥, 6°³¿ù ¹Ì¸¸ÀÇ Á¥¸ÔÀÌ¿Í 4¼¼ ÀÌ»óÀÇ ¾î¸°ÀÌ¿¡°Ô´Â µå¹°°Ô °¨¿°µÈ´Ù. ³²ÀÚ ¾î¸°ÀÌ¿¡°Ô ¸¹°í ¼ºÀο¡°Ôµµ ³ªÅ¸³­´Ù. ¿©¸§Ã¶¿¡ ÁÖ·Î ¹ßº´Çϰí 4~6Àϰ£ÀÇ Àẹ±â¸¦ °ÅÄ£´Ù. Áõ¼¼´Â ´ëü·Î °¡º±´Ù. 1957³â ij³ª´Ù Åä·ÐÅä¿¡¼­ À¯ÇàÇßÀ» ¶§ ·Îºó½¼ µîÀÌ ÀÌ Áõ¼¼¿¡ ´ëÇØ ±â·ÏÇß°í, ´º¿åÁÖ ÄÛ»çŰ¿¡¼­ óÀ½À¸·Î ÀÌ ¹ÙÀÌ·¯½º¸¦ ºÐ¸®½ÃŲ µ¥¼­ ±× Áö¹æ¸íÀ» µû¼­ ¸í¸íÇÏ¿´´Ù. ±× ´ç½Ã º´¿øÃ¼´Â ÄÛ»çŰ A16 ¹ÙÀÌ·¯½º¿´À¸³ª, ÈÄ¿¡ ÄÛ»çŰ A5, A10°ú ¿£Å×·Î ¹ÙÀÌ·¯½º 71Çü¿¡ ÀÇÇØ¼­µµ °°Àº Áõ¼¼ÀÇ º´ÀÌ ³ªÅ¸³­´Ù´Â °ÍÀÌ ¹àÇôÁ³´Ù. ÁÖ·Î ºñ¸» °¨¿°, °æ±¸ °¨¿°À¸·Î Àü¿°µÈ´Ù.
  • Hand Schuller Christian disease
    ÇÑÆ® ½¶·¯ Å©¸®½ºÂù º´, ÇÚµå ½¶·¯ Å©¸®½ºÂù º´, Hand-Schuller-Christian º´
    1. ´Ù¼Ò¼º È£»ê¼º À°¾ÆÁ¾ÀÌ 5¼¼ ÀÌÀü¿¡ ¹ßº´ÇÏ´Â °æ¿ì¿¡ »ç¿ëÇÏ´Â ¿ë¾î. ¹ß¿­, Àü½Å¼º Àμ³, µÎÇÇ¿Í À̰ü ÇǺÎÀÇ Áö·ç¼º ¹ßÁø, ÁßÀÌ¿°, À¯¾çµ¹±â¿° ¹× Ä¡Àº¿°°ú »ó±âµµ ¿°ÁõÀ» ÈçÈ÷ µ¿¹ÝÇÑ´Ù. 2. °æµµÀÇ ¸²ÇÁÀý Á¾´ë, °£ºñ Á¾´ë°¡ ÃÊ·¡µÉ ¼ö ÀÖ°í ÆóÀå³»¿¡ À°¾ÆÁ¾ Çü¼º ¶Ç´Â °£ÇæÀûÀÎ ¹Ì»ý¹° °¨¿°¿¡ ÀÇÇÑ °ÍÀ¸·Î º¸ÀÌ´Â ¹Ì¸¸¼º Æó¿° ¼Ò°ßÀ» º¼ ¼ö ÀÖ´Ù. 3. ¾î¸°ÀÌ ¹× 10´ë Ãʹݿ¡ ¹ßº´Çϸç 3´ë Áõ»óÀ¸·Î´Â ¾È±¸ µ¹ÃâÁõ, °ñ º´¼Ò, ´¢ºØÁõ
  • Hand-Schuller-Christian disease
    ÇÚµå-½¯·¯-Å©¸®½ºÂù º´
  • Hansen's disease
    ÇѼ¾º´, ³ªº´
    ÁÖ·Î ÇÇºÎ¿Í ¸»ÃʽŰæÀ» ħ¹üÇÏ´Â ¸¸¼º À°¾ÆÁ¾¼º °¨¿°ÀÇ ÀÏÁ¾. Mycobacterium le
  • Hartnup disease
    Çϸ£Æ®´©ÇÁ º´
    À¯Àü¼º
  • Hashimoto's disease
    ÇϽø𵵠º´
    °©»ó¼±ÀÇ ÁøÇ༺ ÀÚ°¡ ¸é¿ª ÁúȯÀ¸·Î¼­ ¸²ÇÁ±¸ ħÀ±°ú ¼øÈ¯Áß ÀÚ°¡ Ç×ü¸¦ µ¿¹ÝÇÑ´Ù. ¿©ÀÚ¿¡°Ô Àß ÀϾ°í °¡°èÀû ¼ÒÀÎ °æÇâÀÌ ÀÖ´Ù. ¶§·Î´Â °©»ó¼± ±â´É Ç×ÁøÁõ¿¡ ÈļÓÇÏ¿© ³ªÅ¸³ª¸ç, ȯÀÚ´Â °©»ó¼± Á¾´ë¸¦ ÀÏÀ¸Å°°í Á¡ÁøÀûÀ¸·Î °©»ó¼± ±â´É ÀúÇÏ »óÅ¿¡ ºüÁø´Ù.
  • heart disease
    ½ÉÀå º´, ½É Áúȯ
    ¼øÈ¯±â Áúȯ Áß ½ÉÀåÀÇ Áúȯ. ÀϹÝÀûÀ¸·Î °ü Ç÷°üÀ̳ª ½ÉÀåÀÇ º´µµ Æ÷ÇԵȴÙ. º´º¯ÀÇ ºÎÀ§¿¡ ÀÇÇÑ º´¸®ÇغÎÇÐÀû ºÐ·ù¿Í º´Àο¡ ÀÇÇÑ ºÐ·ù°¡ ÀÌ·ç¾îÁö°í ÀÖ´Ù. ÀüÀÚ´Â ¼ö ½Ê ³â ÀüºÎÅÍ ¾²¿©Á® ¿ÔÀ¸³ª ±Ù³â¿¡ ¿Í¼­ º»ÁúÀûÀÎ ¿øÀÎ ¿ä¹ýÀÌ °¡´ÉÇÏ°Ô µÈ ÀÌÈÄ´Â ÈÄÀÚÀÇ ºÐ·ù°¡ ÀÇÀǰ¡ À־ ¸¹ÀÌ ¾²ÀÌ°Ô µÇ¾ú´Ù. º´º¯ ºÎÀ§·Î´Â ½É³»¸·
  • heavy chain disease
    H ¼âº´, Á߼⺴
    ´ÜŬ·Ð¼ºÀÇ °¨¸¶ ±Û·ÎºÒ¸° ÀÌ»óÀ¸·Î¼­, Ç׿ø¼º °áÁ¤ ÀÎÀÚ°¡ °á¿©µÈ ¸é¿ª ±Û·ÎºÒ¸°ÀÌ »ý»êµÈ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
lung: gallium imaging <radiology> Scans at 48 hrs because 50% of normals show activity at 24 hrs, focal uptake, primary pulmonary malignancy, benign disorder: granuloma, abscess, pneumonia, silicosis, multifocal/diffuse uptake, infection, TB: active lesion, miliary TB, rapidly progressive TB pneumonia, PCP: unimpressive symptoms and CXR, CMV, inflammation: sarcoid, interstitial lung disease (pneumoconiosis, idiopathic pulmonary fibrosis, lymphangitic carcinomatosis), radiation pneumonitis, drugs: bleomycin, amiodarone, contrast lymphangiography (in 50%) see: gallium: indications, uptake with normal chest film
(12 Dec 1998)
lung-grown <medicine> Having lungs that adhere to the pleura.
Source: Websters Dictionary
(01 Mar 1998)
lung, hyperlucent Hyperlucency of one lung with decreased size and vascularity of the lung. It is often associated with bronchiolitis obliterans and with adenovirus infection in childhood.
(12 Dec 1998)
lung perfusion agents <radiology> Tc-99m MAA (macro-aggregated albumin), Tc-99m HAM (human albumin microspheres), dose 4 mCi, particles, size 10 - 90 m, number 200,000 - 400,000, effect 1 : 1000 arterioles embolised
(12 Dec 1998)
lung segmental anatomy <radiology> Right lung, 3 lobes, 10 segments, left lung, 2 lobes, 8 segments
(12 Dec 1998)
lung transplantation The transference of either one or both of the lungs from one human or animal to another.
(12 Dec 1998)
lung unit A respiratory bronchiole together with the alveolar ducts and sacs and pulmonary alveoli into which the respiratory bronchiole leads, considered by some to include the terminal bronchiole and its subdivisions, and called a pulmonary acinus.
(05 Mar 2000)
lung ventilation agents <radiology> Xe-133, most commonly used, Xe-127, t = 36.4 days; photons @ 172, 203, 375 keV, can image V after Q, Kr-81m, very expensive, t = 13 sec; photon 190 keV, can repeat V in each projection, Tc-99m DTPA aerosol, can image V in mult. Projections, image Q after V, 1 mCi most likely to be 50-75 mrad to lung, V/Q imaging
(12 Dec 1998)
lung volume measurements Measurement of the amount of air that the lungs may contain at various points in the respiratory cycle.
(12 Dec 1998)
lung window CT settings of window level and width appropriate to showing lung detail; soft tissues are white or nearly so.
Mediastinal window, CT settings of window level and width appropriate to showing soft tissue structures; the lungs become black at these settings.
Synonym: soft tissue window.
(05 Mar 2000)
lymphangitic lung metastases <radiology> Usually adenocarcinoma, breast, lung, upper GI tract (stomach, pancreas)
(12 Dec 1998)
aaa disease Endemic anaemia of ancient Egypt, ascribed in the Papyrus Ebers to intestinal infestation with ancylostoma; now called ancylostomiasis.
(05 Mar 2000)
ABO haemolytic disease of the newborn Erythroblastosis foetalis due to maternal-foetal incompatibility with respect to an antigen of the ABO blood group; the foetus possesses A or B antigen which is lacking in the mother, and the mother produces immune antibody which causes haemolysis of foetal erythrocytes.
(05 Mar 2000)
accumulation disease A disease characterised by abnormal accumulation of a metabolic product in certain cells and tissues; examples include the mucopolysaccharidoses, lipoidoses.
(05 Mar 2000)
Acosta's disease A condition that results from prolonged exposure to high altitude.
Symptoms include a continuous dry cough, shortness of breath, poor exercise tolerance, dizziness, headache, sleep difficulty, anorexia, confusion, fatigue and a rapid pulse.
Treatment includes the immediate movement to a lower altitude. Prophylaxis has been accomplished successfully with the use of acetazolamide (Diamox).
(27 Sep 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 10
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 10
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 10
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 10
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 10
ÅëÇÕ°Ë»ö ¿Ï·á